| abstract |
A method for predicting in a subject non-small cell lung cancer (NSCLC) comprising: using a test sample obtained from a subject suffering from NSCLC after surgical resection; determining the level of expression of a combination of biomarkers, wherein the combination of biomarkers comprises CBX7, TMPRSS2, GPR116, STX1A, KLK6, SLC16A3, TPX2, UCK2, and PHKA1; and analyze the level of expression to generate a risk score, where the risk score can be used to provide a prognosis of the subject. |